|
Category
|
Session Title
|
CME (7.5)
|
P.A.C.E.® (7.5)
|
NSGC (7.5)
|
|
Biochemical/Metabolic and Therapeutics
|
False Positives in Biochemical Genetics: Challenges and Cautionary Tales
|
1.5
|
1.5
|
1.5
|
|
Biochemical/Metabolic and Therapeutics
|
When The Trial Ends Early: Perspectives on Premature Clinical Trial Closures in Rare Disease Therapeutics
|
1.5
|
1.5
|
1.5
|
|
Biochemical/Metabolic and Therapeutics
|
Do Not Miss Treatable Inborn Errors of Metabolism
|
1.5
|
1.5
|
1.5
|
|
Biochemical/Metabolic and Therapeutics
|
Platform 2 - Biochemical/Metabolic
|
1.5
|
1.5
|
1.5
|
|
Biochemical/Metabolic and Therapeutics
|
Platform 7 - Biochemical/Metabolic
|
1.5
|
1.5
|
1.5
|
|
Category
|
Session Title
|
CME (7.5)
|
P.A.C.E.® (7.5)
|
NSGC (7.5)
|
|
Cancer Genetics and Therapeutics
|
The New Era of Genomic Oncology: Technology, Complexity, and Clinical Impact
|
1.5
|
1.5
|
1.5
|
|
Cancer Genetics and Therapeutics
|
Clonal Hematopoiesis, Somatic and Post-Zygotic Mosaicism in Multigene Cancer Testing for Geneticists
|
1.5
|
1.5
|
1.5
|
|
Cancer Genetics and Therapeutics
|
Medical Diagnostic Challenges (Adult and Cancer)
|
1.5
|
1.5
|
1.5
|
|
Cancer Genetics and Therapeutics
|
Platform 1- Hereditary Cancer and Adult Genetics
|
1.5
|
1.5
|
1.5
|
|
Cancer Genetics and Therapeutics
|
Platform 6 - Cancer and Aneuploidy
|
1.5
|
1.5
|
1.5
|
|
Category
|
Session Title
|
CME (15.0)
|
P.A.C.E.® (15.0)
|
NSGC (15.0)
|
|
Clinical Genetics and Therapeutics
|
Cardinal Signs
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Polygenic Scores and Embryo Screening: Navigating the Clinical and Ethical Applications
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Early Genetics Trainee Forum: Mastering the Challenges of Diagnosing and Managing Overgrowth, Connective Tissue, and Mitochondrial Disorders
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Gene Therapy in Action: Real-World Implementation in Clinical Genetics
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Diagnostic Dilemmas from the Undiagnosed Diseases Network
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Beyond The List – Scope and Implementation of ACMG Secondary Findings
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Bridging Diagnosis and Therapy: The Expanding Role of Somatic Testing in Vascular Anomalies
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Hot Topics in Washington, DC and Impacts to Medical Genetics
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Platform 3 - Integrative Genomics and Translational Discovery
|
1.5
|
1.5
|
1.5
|
|
Clinical Genetics and Therapeutics
|
Platform 4 - Genomic Analysis Tools and Workforce
|
1.5
|
1.5
|
1.5
|
|
Category
|
Session Title
|
CME (6.5)
|
P.A.C.E.® (6.5)
|
NSGC (6.5)
|
|
Education and Research Strategies
|
Uniting Science, Standards, and Policy: Collaborative Approaches for Accelerating Pharmacogenomics Adoption
|
1.5
|
1.5
|
1.5
|
|
Education and Research Strategies
|
Leading the Field, Coming Out in Front
|
1.5
|
1.5
|
1.5
|
|
Education and Research Strategies
|
Demystifying Neurology in Genetic Diagnosis: A Practical Approach for Geneticists
|
1.5
|
1.5
|
1.5
|
|
Education and Research Strategies
|
Ted-Style Talks: Advancing Genomics Engagement
|
1
|
1
|
1
|
|
Education and Research Strategies
|
Featured Platform Presentations
|
1
|
1
|
1
|
|
Category
|
Session Title
|
CME (5.25)
|
P.A.C.E.® (5.0)
|
NSGC (5.25)
|
|
|
Health Services and Implementation
|
2026 ACMG Presidential Plenary Session- The Future of Expanded Newborn Genomic Screening: Promise and Practice
|
1.75
|
1.5
|
1.75
|
|
|
Health Services and Implementation
|
Beyond the Genetics Clinic: Frontline Perspectives on Integrating Genomics in Specialty Care
|
1.5
|
1.5
|
1.5
|
|
|
Health Services and Implementation
|
R. Rodney Howell Symposium - Delivering Pharmacogenomics at Scale: Implementation Strategies That Work
|
2
|
2
|
2
|
|
|
Category
|
Session Title
|
CME (14.0)
|
P.A.C.E.® (14.0)
|
NSGC (14.0)
|
|
|
Laboratory Genetics and Genomics
|
Beyond Uncertainty: Using Functional Assays for Clinical Variant Classification
|
2
|
2
|
2
|
|
|
Laboratory Genetics and Genomics
|
Dilemmas of Omic Technologies for Molecular Diagnosis of Rare Disease
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
The Laws of the Ring: Diagnostic Algorithm, Formation Mechanisms, and Clinical Consequences
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Advances in Genomics with AI: From Patient Selection to Variant Analysis and Beyond
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Laboratory Diagnostic Challenges: Constitutional and Neoplastic Cases in Molecular, Cytogenomic, and Biochemical Genetics Specialties
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Rewriting the Reference: Laboratory and Clinical Applications of the New Human Pangenome Reference
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Genetic Counselor Forum - Consanguinity: Counseling, Laboratory and Ethical Considerations in the Genomic Era
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Platform 8 - Rapid WGS and Newborn Screening
|
1.5
|
1.5
|
1.5
|
|
|
Laboratory Genetics and Genomics
|
Platform 5 - New Laboratory Techniches (Long read, OGM, RNA, PRS)
|
1.5
|
1.5
|
1.5
|
|
|
Category
|
Session Title
|
CME (4.5)
|
P.A.C.E.® (4.5)
|
NSGC (4.5)
|
|
|
Prenatal Genetics
|
Non-invasive fetal sequencing (NIFS) is coming: Are you ready?
|
1.5
|
1.5
|
1.5
|
|
|
Prenatal Genetics
|
Reproductive Carrier Screening: Is It Time for Whole Genome Testing?
|
1.5
|
1.5
|
1.5
|
|
|
Prenatal Genetics
|
Challenge the Experts - Pediatric and Prenatal Diagnostic Dilemmas (rare knowns and unknowns)
|
1.5
|
1.5
|
1.5
|
|
|
|
Total Accredited Educational Hours
|
60.25
|
60
|
60.25
|
|